Observation of Clinical Treatment Efficacy in Severe Heart Failure of Geriatric Cardiology

Qi Yuan

简介

Objective: To explore the clinical treatment efficacy of severe heart failure in geriatric cardiology.Methods: A total of 122 cases of severe heart failure patients admitted to our hospital from January 2022 to December 2023 were selected as the research subjects. The patients were divided into two groups using digital random grouping method, with 61 cases in each group. The control group was treated with metoprolol, while the experimental group was treated with metoprolol combined with eplerenone hydrochlorothiazide. The occurrence rate of adverse reactions and treatment efficacy of clinical indicators were compared between the two groups.Results: There was no significant difference in the incidence of adverse reactions (P > 0.05); the clinical indicators of the experimental group were better than those of the control group, and the total effective rate of treatment was higher than that of the control group. The difference in comparison results was statistically significant (P < 0.05). Conclusion: For the treatment of severe heart failure in geriatric patients in cardiology,metoprolol combined with eplerenone hydrochlorothiazide can be used, which can significantly improve the clinical signs of patients, increase the total effective rate of treatment, and will not significantly increase the risk of adverse reactions. It is worth further promotion and application.

关键字

Cardiology; Severe heart failure; Geriatric patients

全文

PDF

参考文献

版权所有 © 2024 Qi Yuan 出版时间:2024-02-27
本作品采用以下许可协议授权： 知识共享 署名 4.0 国际许可协议